Replay available

Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call

Bio-Rad Laboratories, Inc. (NYSE: BIO) Q2 2026 earnings conference call, held 2026-08-04. Replay captured from the company's public earnings webcast.

Tue, August 4, 2026 at 5:00 PMendedReplay
Bio-Rad Laboratories, Inc. (BIO) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Ruben Argueta

Head of Investor Relations

John DiVincenzo

President and Chief Operating Officer

Roop Lakkaraju

Executive Vice President and Chief Financial Officer

Norman Schwartz

Chief Executive Officer

Jack Nehan

Analyst, Operon Research

Tycho Peterson

Analyst, Jefferies

Dan Leonard

Analyst, RBC Capital Markets

Albert Hu

Analyst, Citi

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. My name is Lisa, and I will be your conference operator today. At this time, I would like to welcome everyone to Bio Rad's Second Quarter twenty twenty six Results Conference Call and Webcast. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. I would now like to turn the conference over to Ruben Argueda, BIORAD's Head of Investor Relations. You may begin. Thank you, operator. Good afternoon, everyone, and thank you for joining us. Today, we will review the financial results for the second quarter ended 06/30/2026, and provide an update on key business trends for BIORAD. With me on the call today are Norman Schwartz, our Chief Executive Officer John DiVincenzo, President and Chief Operating Officer and Roop Lakaraju, Executive Vice President and Chief Financial Officer. Before we begin our review, I would like to remind everyone that we will be making forward looking statements about management's goals, plans and expectations, our future financial performance and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Our actual results may differ materially from these plans, goals and expectations. You should not place undue reliance on these forward looking statements, and I encourage you to review our filings with the SEC where we discuss in detail the risk factors in our business. The company does not intend to update any forward looking statements made during the call today. Finally, our remarks today will include references to non GAAP financials, including net income and diluted earnings per share, which are financial measures that are not defi...

More from Bio-rad Laboratories, Inc.